Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: A potential mechanism of fluoroquinolone-associated aortopathy - PubMed (original) (raw)
. 2019 Jan;157(1):109-119.e2.
doi: 10.1016/j.jtcvs.2018.08.079. Epub 2018 Sep 21.
Affiliations
- PMID: 30528439
- DOI: 10.1016/j.jtcvs.2018.08.079
Free article
Induction of human aortic myofibroblast-mediated extracellular matrix dysregulation: A potential mechanism of fluoroquinolone-associated aortopathy
David G Guzzardi et al. J Thorac Cardiovasc Surg. 2019 Jan.
Free article
Abstract
Objectives: Fluoroquinolone (FQ) antibiotics are associated with adverse aortic clinical events. We assessed human aortic myofibroblast-mediated extracellular matrix (ECM) dysregulation as a possible cellular mechanism underlying FQ-associated aortopathy.
Methods: Human aortic myofibroblasts were isolated from patients with aortopathy undergoing elective ascending aortic resection (N = 9). The capacity for extracellular matrix degradation in cells exposed to FQ was assessed by multiplex analysis of secreted matrix metalloproteinases relative to tissue inhibitors of matrix metalloproteinases (TIMPs). Direct evaluation of extracellular matrix degradation was investigated in human aortic cells using a 3-dimensional gelatin-fluorescein isothiocyanate fluorescence microgel assay. Aortic cellular collagen-1 expression following FQ exposure was determined by immunoblotting and immunofluorescent staining. Cell apoptosis, necrosis, and metabolic viability was determined by annexin-V, propidium iodide staining, and water-soluble tetrazolium salt (WST1) assay.
Results: FQ exposure significantly decreased aortic cell TIMP-1 (P = .004) and TIMP-2 (P = .0004) protein expression compared with vehicle control. The ratio of matrix metalloproteinase-9/TIMP-2 was increased suggesting an increased capacity for extracellular matrix degradation (P = .01). In collagen gels, we show a trend toward increased aortic myofibroblast-mediated collagen fiber degradation with FQ exposure (P = .09). Similarly, FQ exposure attenuated collagen-1 expression as assessed by immunoblotting (P = .002) and immunofluorescence (P = .02). Cell apoptosis, necrosis, and metabolic viability was not significantly influenced by FQ exposure.
Conclusions: For the first time, we document a putative mechanism underlying FQ-associated aortopathy whereby decreased TIMP expression with impaired compensatory collagen-1 expression results in human aortic myofibroblast-mediated extracellular matrix dysregulation. These novel data may provide a cellular and molecular mechanism to explain the established clinical association between FQ exposure and acute aortic events.
Keywords: aortopathy; extracellular matrix; fluoroquinolone.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Comment in
- True, true, or unrelated? Fluoroquinolones and aortic disease.
Balsam LB. Balsam LB. J Thorac Cardiovasc Surg. 2019 Jan;157(1):120-121. doi: 10.1016/j.jtcvs.2018.09.053. Epub 2018 Oct 6. J Thorac Cardiovasc Surg. 2019. PMID: 30414764 No abstract available. - The dark side of fluoroquinolones.
Mennander AA. Mennander AA. J Thorac Cardiovasc Surg. 2019 Jan;157(1):122-123. doi: 10.1016/j.jtcvs.2018.09.021. Epub 2018 Sep 29. J Thorac Cardiovasc Surg. 2019. PMID: 30482528 No abstract available.
Similar articles
- Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
Truffi M, Sorrentino L, Monieri M, Fociani P, Mazzucchelli S, Bonzini M, Zerbi P, Sampietro GM, Di Sabatino A, Corsi F. Truffi M, et al. Inflamm Bowel Dis. 2018 Jan 18;24(2):332-345. doi: 10.1093/ibd/izx008. Inflamm Bowel Dis. 2018. PMID: 29361086 - Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA, Ngu JM, Mewhort HE, Lipon BD, Teng G, Guzzardi DG, Malik G, Belke DD, Fedak PW. Svystonyuk DA, et al. J Transl Med. 2015 May 7;13:147. doi: 10.1186/s12967-015-0510-4. J Transl Med. 2015. PMID: 25948488 Free PMC article. - Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results.
Kang S, Verma S, Hassanabad AF, Teng G, Belke DD, Dundas JA, Guzzardi DG, Svystonyuk DA, Pattar SS, Park DSJ, Turnbull JD, Duff HJ, Tibbles LA, Cunnington RH, Dyck JRB, Fedak PWM. Kang S, et al. Can J Cardiol. 2020 Apr;36(4):543-553. doi: 10.1016/j.cjca.2019.08.033. Epub 2019 Aug 29. Can J Cardiol. 2020. PMID: 31837891 - Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
Jun C, Fang B. Jun C, et al. BMC Cardiovasc Disord. 2021 Sep 28;21(1):470. doi: 10.1186/s12872-021-02258-1. BMC Cardiovasc Disord. 2021. PMID: 34583637 Free PMC article. Review. - Fluoroquinolones: old drugs, putative new toxicities.
Bove C, Baldock RA, Champigneulle O, Martin L, Bennett CL. Bove C, et al. Expert Opin Drug Saf. 2022 Nov;21(11):1365-1378. doi: 10.1080/14740338.2022.2147924. Epub 2022 Nov 21. Expert Opin Drug Saf. 2022. PMID: 36384376 Review.
Cited by
- Effect of FluoRoquinolones on Aortic Growth, aortic stIffness and wave refLEctionS (FRAGILES study).
Gardikioti V, Georgakopoulos C, Solomou E, Lazarou E, Fasoulakis K, Terentes-Printzios D, Tsioufis K, Iliopoulos D, Vlachopoulos C. Gardikioti V, et al. Life (Basel). 2024 Aug 9;14(8):992. doi: 10.3390/life14080992. Life (Basel). 2024. PMID: 39202735 Free PMC article. - Insights on the Pathogenesis of Aneurysm through the Study of Hereditary Aortopathies.
Creamer TJ, Bramel EE, MacFarlane EG. Creamer TJ, et al. Genes (Basel). 2021 Jan 27;12(2):183. doi: 10.3390/genes12020183. Genes (Basel). 2021. PMID: 33514025 Free PMC article. Review. - Use of fluoroquinolones and the risk of aortic and mitral regurgitation: A nationwide case-crossover study.
Chou AH, Lin CP, Chen CY, Wu VC, Cheng YT, Chan YH, Hsiao FC, Chen DY, Hung KC, Chu PH, Chen SW. Chou AH, et al. PLoS One. 2024 Jul 24;19(7):e0307480. doi: 10.1371/journal.pone.0307480. eCollection 2024. PLoS One. 2024. PMID: 39047047 Free PMC article. - Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A case report.
Monti M, Sullo FG, Iamurri AP, Gianni C, Silimbani P, Bartolini G, Valgiusti M, Esposito L, Montanari D, Antonini S, Frassineti GL. Monti M, et al. Oncol Lett. 2022 May 12;24(1):202. doi: 10.3892/ol.2022.13324. eCollection 2022 Jul. Oncol Lett. 2022. PMID: 35720484 Free PMC article. - Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?
Rusu A, Munteanu AC, Arbănași EM, Uivarosi V. Rusu A, et al. Pharmaceutics. 2023 Mar 1;15(3):804. doi: 10.3390/pharmaceutics15030804. Pharmaceutics. 2023. PMID: 36986665 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous